España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
InflaRx
IFRX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.24
-0.01000
-0.44%
At close: -
$2.25
0.01000
0.45%
After Hours: Jan 28, 4:02 PM EDT
Get Report
Comment
InflaRx (IFRX) Forecast
News
Earnings
InflaRx (IFRX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for InflaRx (NASDAQ:IFRX) Stock
InflaRx Stock (NASDAQ: IFRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 16, 2025
HC Wainwright & Co. Reiterates Buy on InflaRx...
Benzinga Newsdesk
Wednesday, January 15, 2025
InflaRx Receives European Commission Approval...
Benzinga Newsdesk
Friday, December 20, 2024
HC Wainwright & Co. Reiterates Buy on InflaRx...
Benzinga Newsdesk
InflaRx Doses First Patient In Phase 2a Baske...
Benzinga Newsdesk
Friday, November 15, 2024
HC Wainwright & Co. Reiterates Buy on InflaRx...
Benzinga Newsdesk
InflaRx shares are trading higher after the c...
Benzinga Newsdesk
InflaRx Says CHMP of European Medicines Agenc...
Benzinga Newsdesk
Monday, November 11, 2024
HC Wainwright & Co. Reiterates Buy on InflaRx...
Benzinga Newsdesk
Friday, November 08, 2024
InflaRx's Q3 Cash, Cash Equivalents And Marke...
Benzinga Newsdesk
InflaRx Q3 2024 GAAP EPS €(0.30) Misses €(0.2...
Benzinga Newsdesk
Thursday, November 07, 2024
Earnings Preview: InflaRx
Benzinga Insights
Wednesday, September 25, 2024
HC Wainwright & Co. Reiterates Buy on InflaRx...
Benzinga Newsdesk
InflaRx Announced The E-poster Presentation O...
Benzinga Newsdesk
Thursday, August 08, 2024
InflaRx's Cash, Cash Equivalents And Marketab...
Benzinga Newsdesk
InflaRx Q2 2024 GAAP EPS €(0.24) Misses €(0.2...
Benzinga Newsdesk
Monday, June 24, 2024
HC Wainwright & Co. Reiterates Buy on InflaRx...
Benzinga Newsdesk
InflaRx shares are trading higher after the c...
Benzinga Newsdesk
InflaRx Announces GOHIBIC (Vilobelimab) Selec...
Benzinga Newsdesk
Thursday, June 06, 2024
HC Wainwright & Co. Reiterates Buy on InflaRx...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on InflaRx...
Benzinga Newsdesk
Wednesday, May 08, 2024
InflaRx Q1 2024 GAAP EPS $(0.18) Beats $(0.22...
Benzinga Newsdesk
Friday, March 22, 2024
HC Wainwright & Co. Reiterates Buy on InflaRx...
Benzinga Newsdesk
Thursday, March 21, 2024
InflaRx's INF904 Will Initially Target Chroni...
Benzinga Newsdesk
InflaRx Will Focus Development Activities And...
Benzinga Newsdesk
InflaRx FY EPS €(0.78) Down From €(0.67) YoY,...
Benzinga Newsdesk
Earnings Scheduled For March 21, 2024
Benzinga Insights
Wednesday, March 20, 2024
Earnings Preview: InflaRx
Benzinga Insights
Friday, January 26, 2024
Why Tellurian Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, January 25, 2024
HC Wainwright & Co. Maintains Buy on InflaRx,...
Benzinga Newsdesk
Thursday, January 04, 2024
InflaRx shares are trading higher after the c...
Benzinga Newsdesk
InflaRx Reports Topline Results From Multiple...
Benzinga Newsdesk
Monday, November 06, 2023
InflaRx Announces That The First Patient Has ...
Benzinga Newsdesk
Friday, November 03, 2023
Why DigitalOcean Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Thursday, November 02, 2023
Raymond James Maintains Strong Buy on InflaRx...
Benzinga Newsdesk
Tuesday, September 12, 2023
HC Wainwright & Co. Reiterates Buy on InflaRx...
Benzinga Newsdesk
Monday, September 11, 2023
InflaRx Announces Topline Results from the Si...
Benzinga Newsdesk
Thursday, August 31, 2023
HC Wainwright & Co. Reiterates Buy on InflaRx...
Benzinga Newsdesk
Wednesday, August 30, 2023
InflaRx's Marketing Authorization Application...
Benzinga Newsdesk
Friday, August 11, 2023
HC Wainwright & Co. Reiterates Buy on InflaRx...
Benzinga Newsdesk
Thursday, August 10, 2023
InflaRx Q2 Adj EPS $(0.15) Beats $(0.34) Esti...
Benzinga Newsdesk
Friday, June 30, 2023
InflaRx Files For Mixed Shelf Of Up To $250M
Benzinga Newsdesk
Monday, June 12, 2023
Why Oncorus Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Tuesday, May 16, 2023
WuXi Biologics Taps InflaRx to Advance Gohibi...
Benzinga Newsdesk
Friday, May 12, 2023
HC Wainwright & Co. Reiterates Buy on InflaRx...
Benzinga Newsdesk
Raymond James Maintains Strong Buy on InflaRx...
Benzinga Newsdesk
Friday, April 21, 2023
HC Wainwright & Co. Maintains Buy on InflaRx,...
Benzinga Newsdesk
Wednesday, April 12, 2023
Apogee Enterprises, Sportsman's Warehouse And 3 Stocks To Watch Heading Into Wednesday
Lisa Levin
Reported Late Tuesday April 11, InflaRx Announces Pricing Of $40M Public Offering Of 9,411,765 Ordinary Shares At A Price Of $4.25/Share
Happy Mohamed
Tuesday, April 11, 2023
InflaRx Announces Public Offering Of Ordinary...
Michael Horton
Thursday, April 06, 2023
Analyst Expectations for InflaRx's Future
Benzinga Insights
Show More
